Drug maker Allchem Lifescience has filed preliminary papers with markets regulator Sebi seeking its approval to raise funds through an initial public offering (IPO). The Gujarat-based company’s proposed IPO comprises fresh issue of equity shares aggregating up to Rs 190 crore and an offer for sale (OFS) of 71.55 lakh equity shares by promoters, according to the draft red herring prospectus (DRHP).
Ather Energy IPO to open for subscription as GMP stays weak. Should you bid?
Ather Energy’s IPO opens today, aiming to raise ₹2,981 crore through fresh equity and an offer for sale, where promoters and investors like Tiger Global